(Q44415316)

2 December 2017

Role of E-cadherins in development of lymphatic tumor emboli (English)

1 reference

2 December 2017

Role of E‐cadherins in development of lymphatic tumor emboli (English)

1 reference

27 December 2023

1 reference

27 December 2023

author name string

Anita Gupta

series ordinal

1

1 reference

2 December 2017

Sunil Badve

series ordinal

3

1 reference

2 December 2017

Charuhas G. Deshpande

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712492

27 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.11332

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12712492

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.11332

27 December 2023

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.11332

27 December 2023

1 reference

27 December 2023

1 reference

2 December 2017

97

1 reference

2 December 2017

9

1 reference

2 December 2017

2341-2347

1 reference

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis

2 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

E-cadherin relates to EGFR expression and lymph node metastasis in primary breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Solution structure of the epithelial cadherin domain responsible for selective cell adhesion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Cadherin cell adhesion receptors as a morphogenetic regulator

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Structural basis of cell-cell adhesion by cadherins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Structural basis of calcium-induced E-cadherin rigidification and dimerization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

The role of cadherin-mediated adhesion in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Altered expression of E-cadherin in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

E-cadherin quantitative immunocytochemical assays in breast carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Persistent E-cadherin expression in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11332

7 January 2021

Identifiers

DOI

10.1002/CNCR.11332

1 reference

2 December 2017

1 reference